Search

Your search keyword '"Asunción Lafuente"' showing total 28 results

Search Constraints

Start Over You searched for: Author "Asunción Lafuente" Remove constraint Author: "Asunción Lafuente"
28 results on '"Asunción Lafuente"'

Search Results

1. Clinical value of plasma pTau181 to predict Alzheimer's disease pathology in a large real-world cohort of a memory clinicResearch in context

2. A randomized, open-label clinical trial in mild cognitive impairment with EGb 761 examining blood markers of inflammation and oxidative stress

3. The role of sex and gender in the selection of Alzheimer patients for clinical trial pre-screening

4. Safety, tolerability and immunogenicity of an active anti-Aβ40 vaccine (ABvac40) in patients with Alzheimer’s disease: a randomised, double-blind, placebo-controlled, phase I trial

5. Exploring Genetic Associations of Alzheimer’s Disease Loci With Mild Cognitive Impairment Neurocognitive Endophenotypes

6. Correction: Blood Amyloid Beta Levels in Healthy, Mild Cognitive Impairment and Alzheimer’s Disease Individuals: Replication of Diastolic Blood Pressure Correlations and Analysis of Critical Covariates.

7. Blood amyloid beta levels in healthy, mild cognitive impairment and Alzheimer's disease individuals: replication of diastolic blood pressure correlations and analysis of critical covariates.

8. New insights into the genetic etiology of Alzheimer's disease and related dementias

9. Managing Clinical Trials for Alzheimer’s Disease During the COVID-19 Crisis: Experience at Fundació ACE in Barcelona, Spain

10. The role of sex and gender in the selection of Alzheimer patients for clinical trial pre-screening

11. How gender and sex influence clinical trial recruitment in Alzheimer's disease: Findings from Fundació ACE Barcelona Alzheimer Treatment and Research Center

12. Gender and sex bias in clinical trial recruitment in Alzheimer's disease: Findings from Fundació ACE

13. Patient Engagement: The Fundació ACE Framework for Improving Recruitment and Retention in Alzheimer’s Disease Research

14. Safety, tolerability and immunogenicity of an active anti-Aβ40 vaccine (ABvac40) in patients with Alzheimer’s disease: a randomised, double-blind, placebo-controlled, phase I trial

15. Genome-wide association analysis of dementia and its clinical endophenotypes reveal novel loci associated with Alzheimer’s disease and three causality networks of AD: the GR@ACE project

16. Genome-wide association analysis of dementia and its clinical endophenotypes reveal novel loci associated with Alzheimer's disease and three causality networks : The GR@ACE project

17. Exploring Genetic Associations of Alzheimer’s Disease Loci With Mild Cognitive Impairment Neurocognitive Endophenotypes

18. Safety, tolerability and immunogenicity of an active anti-Aβ

19. Exploring APOE genotype effects on Alzheimer's disease risk and amyloid β burden in individuals with subjective cognitive decline: The FundacioACE Healthy Brain Initiative (FACEHBI) study baseline results

20. Efficacy and Safety of Plasma Exchange with 5% Albumin to Modify Cerebrospinal Fluid and Plasma Amyloid-β Concentrations and Cognition Outcomes in Alzheimer's Disease Patients: A Multicenter, Randomized, Controlled Clinical Trial

21. P2‐087: Genetic Determinants of Alzheimer's Disease Progression: Exploratory Analysis of International Genomics of Alzheimer Project (IGAP) Genetic Markers in MMSE Rate of Decline and GDS

22. P2‐399: RAMCIP PROJECT, A ROBOTIC ASSISTANT TO SUPPORT ALZHEIMER'S DISEASE PATIENTS AT HOME: A NOVEL APPROACH IN CAREGIVING

23. P2‐283: An interdisciplinary portrait of dementia: The reality of barcelona, spain

24. P3‐196: Cognitive composites and prodromal Alzheimer's disease

25. Association between cell-bound blood amyloid-β(1 - 40) levels and hippocampus volume

26. Blood Amyloid Beta Levels in Healthy, Mild Cognitive Impairment and Alzheimer’s Disease Individuals: Replication of Diastolic Blood Pressure Correlations and Analysis of Critical Covariates

27. P4‐243: ATP5H/KCTD2 locus and Alzheimer's disease: An etiological link between key brain functions and dementia

28. P1‐185: 'Open House' Screening Program to Identify Cognitive Impairment Among Community‐Dwelling Middle‐Aged/Elderly People

Catalog

Books, media, physical & digital resources